Related Experiment Video
Updated: Aug 28, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
Prothrombotic risk factors in childhood stroke and venous thrombosis
C Heller1, S Becker, I Scharrer
1Department of Paediatrics, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. cheller@uni-frankfurt.de
Insights
FV Leiden mutation and protein C deficiency increase the risk of cerebral infarction and venous thrombosis in children. These thrombophilias are significant risk factors for pediatric stroke, unlike in adults.
Area of Science:
- Pediatric Hematology
- Neurology
- Thrombosis Research
Background:
- Venous thromboses in children are often linked to hematological disorders.
- Studies on hemostasis disorders influencing pediatric stroke are scarce.
- Investigating prothrombotic risk factors in pediatric stroke is crucial.
Purpose of the Study:
- To compare prothrombotic risk factors in children with cerebral infarction versus venous thrombosis.
- To assess the prevalence of specific thrombophilias in these pediatric patient groups.
- To determine the association of thrombophilias with pediatric stroke and venous thrombosis.
Main Methods:
- Comparative analysis of 26 children with cerebral infarction and 17 with venous thrombosis.
- Screening for prothrombotic risk factors including FV Leiden mutation and protein C deficiency.
- Comparison of patient group prevalences with 150 healthy pediatric controls.
Main Results:
- FV Leiden mutation and/or protein C deficiency were found in 26.9% of cerebral infarction patients and 53% of venous thrombosis patients.
- These thrombophilias significantly increased the risk of cerebral infarction (OR 5.77) and venous thrombosis (OR 19.9) in children compared to controls.
- The association of thrombophilia with cerebral infarction in children contrasts with findings in adult patients.
Conclusions:
- FV Leiden mutation and protein C deficiency are identified as potential contributors to the multifactorial etiology of early childhood stroke.
- These findings highlight the importance of screening for thrombophilias in pediatric stroke cases.
- The results underscore differences in thrombophilia's role in pediatric versus adult cerebral infarction.
Unlabelled:
Many studies have shown a high percentage of venous thromboses in children to be associated with haematological disorders. However, studies assessing the influence of haemostaseological disorders on paediatric stroke are rare. We compared 26 children with cerebral infarction (median age 2 months, range 0-16.2 years) and 17 with venous thrombosis (median age 4.5 years, range 0-17 years) with regard to prothrombotic risk factors. Prothrombotic disorders were found in 8 out of 26 patients with cerebral infarction (FV Leiden mutation: n = 4; protein C deficiency: n = 1; FV Leiden mutation + protein C deficiency: n = 2; prothrombin mutation G20210A: n = 1) and in 13 out of 17 with venous thrombosis (FV Leiden mutation n = 3; protein C deficiency n = 5; elevated HRGP + PAI: n = 1, combined deficiency of AT, protein C and plasminogen: n = 1; F XII deficiency: n = 1; lupus anticoagulans n = 1; FV Leiden + F XII deficiency + lupus anticoagulans + PAI: n = 1). Comparison of these prevalences with those of 150 healthy paediatric controls showed in children with FV Leiden mutation and/or protein C deficiency an increased risk of cerebral infarction (patients vs. controls: 26.9% vs. 6%; OR 5.77; 95%-CI 1.92-17.3; P = 0.0031) as well as of venous thrombosis (53% vs. 5.3% 19.9; 95%-CI 6-65.6; P < 0.0001). This result is in contrast with reports on thrombophilia in cerebral infarction in adult patients.
Conclusion:
Our results indicate that FV Leiden mutation and protein C deficiency may contribute to the multifactorial aetiology of stroke in early childhood.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Varicose Veins I: Introduction
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke l: Introduction

